AMR DetecTool
A breakthrough device for the rapid detection of antimicrobial resistance
- Durada
- 01/01/2020 - 31/12/2022
- Coordinador
- Centre aux Energies Atomiques, CEA (France)
- Finançadors
- EIT Health
- Pàgina web
- https://amrdetect.eu
The AMR DetecTool project (2020-2022) is an innovation process involving 14 professional organisations from across Europe. Its goal is to validate and bring to market a rapid test for the detection of antimicrobial resistance (AMR) in only 30 minutes. This device is ultimately to support hospitals in saving patient lives and saving treatment costs.
Total Funding
2,789,898 €
Our Team
ISGlobal Team
- Clara Ballesté Associated Research Professor i Coordinadora de la Iniciativa de Resistències Antimicrobianes
- Jordi Bosch Associated Researcher
- Aleix Cabrera Tècnic Comunicació
- Jordi Vila Research Professor, Director de la Iniciativa de Resistències Antimicrobianes i del programa d'Infeccions Víriques i Bacterianes
Altres projectes
Veure projectes passatsCOMBACTE
Combatent la Resistència Bacteriana a Europa
Desenvolupament d'estratègies per a l'Eradicació de la Malaltia de Pian
Eradicació del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
HU-MEN (High frequency Ultrasound-based MENingitis screening)
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Xpatial-TB
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
WHIP3TB
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
New antibacterial agents against 'Acinetobacter baumannii'
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Desarrollo de nuevos metaloantibióticos frente a patógenos causantes de infecciones crónicas en pacientes con fibrosis quística
VINCI
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
INTE-AFRICA
Integrating and decentralizing diabetes and hypertension services in Africa
AVATAR
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
SAFE - Superbug Awareness For Education
COVID-PREG
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT)
Estudio piloto para evaluar el potencial de la ivermectina para reducir la transmisión de COVID-19
Encuesta serológica Cendea de Cizur
Cendea de Cizur
CoViproteHCt
Projecte de Recerca en Resposta Immunitària i Epidemiologia de Malalties Infeccioses
Conèixer la propagació. Entendre la protecció
ANTICOV
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
HBV-COMSAVA
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Stool4TB
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Hep C Free Baleares
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.